McKesson reports 10 percent revenue growth, Leidos Q3 revenues hit $1.3 billion & more – 4 RCM company key notes

Here are four news updates on key healthcare revenue cycle management companies.

Advertisement

Leidos reported $1.3 billion in revenues for the third quarter of 2015, up 2 percent from $1.28 billion in the third quarter of 2015.

MedAssets‘ stock has a price target of $39.60 per share after hitting a new 52-week high, according to a Financial Magazin report.

McKesson posted a 10 percent growth in revenue for the second quarter of 2016, but gross profit dipped from $2.86 million last year to $2.84 million this year.

Mediware Information Systems, a post-acute care software company, expanded its denial management solutions offerings through its partnership with ZirMed.

If you have a question, issue or note to suggest on revenue cycle management company, please contact Carrie Pallardy at cpallardy@beckershealthcare.com.

More articles on finance issues:
Cleveland Clinic vs. Mayo Clinic: 5 key comparisons, 2 amazing institutions
House approves budget deal that includes payment cuts to HOPDs
RCM tip of the day: Use comparative metrics

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Download Whitepaper

The cost-saving opportunity most health systems overlook

Many hospitals and health systems scrutinize staffing, service lines, and payer contracts for savings. Fewer look at one of their largest assets: real estate.…

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.